Kiroku is registered with the MHRA as a Class I medical device, which means it is a low-risk device that has a minimal potential to cause harm to the user. MHRA guidance (29 July 2026) sets out which AI scribe functions are regulated as medical devices. Kiroku can summarise medical information, write communications and provide feedback and recommendations on medical conversations. Kiroku's notes are always reviewed and approved by the clinician.